Correlation Engine 2.0
Clear Search sequence regions


  • adult (2)
  • cognitive (1)
  • dry mouth (1)
  • female (1)
  • gabapentin (3)
  • help (1)
  • herbal (1)
  • hot flashes (1)
  • hot flushes (1)
  • humans (1)
  • neurokinin receptor (1)
  • phase (1)
  • pregabalin (1)
  • sleep (1)
  • sleep problems (1)
  • SSRIs (2)
  • therapies (3)
  • weak (1)
  • women (3)
  • Sizes of these terms reflect their relevance to your search.

    Women are living a significant portion of their adult lives in the post-reproductive phase, and many seek help for debilitating menopausal symptoms. Every individual's experience of menopausal transition is unique. Adopting a holistic approach to managing the menopause using a combination of lifestyle, hormonal, and non-hormonal interventions is key to maximise the quality of life of affected women. However, many opt to use non hormonal options or have contraindications to using hormonal therapy. Studies have shown that several pharmacological non-hormonal medications such as SSRIs, SSRI/SNRIs, Gabapentin, and Pregabalin are effective for managing vasomotor symptoms as well as other menopausal symptoms. Their main side effects are dry mouth, nausea, constipation, reduced libido, and loss of appetite. Clonidine is the only non-hormonal drug which is licenced for control of vasomotor symptoms in the UK, but has several side effects including dizziness and sleep disturbance. Cognitive Behavioural Therapy is recommended as a treatment for anxiety, sleep problems and vasomotor symptoms related to menopausal transition. Evidence for clinical efficacy and safety of herbal remedies and alternative therapies remains weak. Studies with neurokinin receptor 3 antagonists on women with hot flushes have shown improvement in vasomotor symptoms and results of large-scale studies are awaited. Copyright © 2023 Elsevier Ltd. All rights reserved.

    Citation

    Bassel H Al Wattar, Vikram Talaulikar. Non-oestrogen-based and complementary therapies for menopause. Best practice & research. Clinical endocrinology & metabolism. 2024 Jan;38(1):101819

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37659918

    View Full Text